Aixiang Wang

1.1k total citations
59 papers, 861 citations indexed

About

Aixiang Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Aixiang Wang has authored 59 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Materials Chemistry. Recurrent topics in Aixiang Wang's work include Renal cell carcinoma treatment (12 papers), Quantum Dots Synthesis And Properties (9 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Aixiang Wang is often cited by papers focused on Renal cell carcinoma treatment (12 papers), Quantum Dots Synthesis And Properties (9 papers) and Bladder and Urothelial Cancer Treatments (9 papers). Aixiang Wang collaborates with scholars based in China, Australia and United Kingdom. Aixiang Wang's co-authors include Shoufang Xu, Hongzhi Lu, Lingxin Chen, Shaobo Han, Jinhua Li, Xingliang Song, Guohua Jia, Jian‐Lin Wu, Shiqing Xu and Zhun Wang and has published in prestigious journals such as Chemical Society Reviews, Journal of Clinical Oncology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Aixiang Wang

56 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aixiang Wang China 14 338 198 194 177 122 59 861
David Ramos Spain 21 212 0.6× 195 1.0× 51 0.3× 343 1.9× 192 1.6× 74 1.4k
K. Morita Japan 19 178 0.5× 143 0.7× 51 0.3× 340 1.9× 145 1.2× 86 959
Qing Han China 16 133 0.4× 441 2.2× 269 1.4× 327 1.8× 178 1.5× 49 1.2k
Simindokht Shirvani‐Arani Iran 13 96 0.3× 188 0.9× 119 0.6× 30 0.2× 54 0.4× 63 654
Enza Torino Italy 21 354 1.0× 60 0.3× 53 0.3× 165 0.9× 594 4.9× 43 1.2k
Yousef Fazaeli Iran 15 309 0.9× 79 0.4× 55 0.3× 87 0.5× 271 2.2× 63 744
Haibo Xing China 16 244 0.7× 56 0.3× 35 0.2× 364 2.1× 234 1.9× 43 946
Hidetoshi Inoue Japan 16 131 0.4× 69 0.3× 51 0.3× 93 0.5× 34 0.3× 80 597
Keqin Deng China 24 474 1.4× 578 2.9× 76 0.4× 664 3.8× 283 2.3× 64 1.8k
S. Basu India 15 203 0.6× 63 0.3× 78 0.4× 81 0.5× 84 0.7× 70 725

Countries citing papers authored by Aixiang Wang

Since Specialization
Citations

This map shows the geographic impact of Aixiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixiang Wang more than expected).

Fields of papers citing papers by Aixiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixiang Wang. The network helps show where Aixiang Wang may publish in the future.

Co-authorship network of co-authors of Aixiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Aixiang Wang. A scholar is included among the top collaborators of Aixiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixiang Wang. Aixiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bai, Bing, Chengxi Zhang, Yongjiang Dou, et al.. (2023). Correction: Atomically flat semiconductor nanoplatelets for light-emitting applications. Chemical Society Reviews. 52(4). 1519–1519. 1 indexed citations
4.
Zhu, Shimiao, Yang Zhao, Zheng Zhang, et al.. (2023). HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell Death and Disease. 14(3). 215–215. 6 indexed citations
5.
Qiu, Yongkang, et al.. (2023). Alpha-fetoprotein-elevated postpubertal testicular teratoma with retroperitoneal metastasis on 18F-FDG PET/CT: case report and literature review. Frontiers in Medicine. 10. 1269587–1269587. 1 indexed citations
6.
Huang, Wenpeng, et al.. (2023). Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report. Frontiers in Medicine. 10. 1266630–1266630. 2 indexed citations
7.
Chen, Jiayi, Derek Hao, Wei Chen, et al.. (2023). Engineering Colloidal Metal‐Semiconductor Nanorods Hybrid Nanostructures for Photocatalysis. Chinese Journal of Chemistry. 41(22). 3050–3062. 7 indexed citations
8.
Huang, Wenpeng, Yongkang Qiu, Aixiang Wang, & Lei Kang. (2023). Pancreatic cancer detected with 18F-FDG PET/CT in IgG4-related disease patient. Revista Española de Enfermedades Digestivas. 115(12). 742–744.
9.
Bai, Bing, Chengxi Zhang, Yongjiang Dou, et al.. (2022). Atomically flat semiconductor nanoplatelets for light-emitting applications. Chemical Society Reviews. 52(1). 318–360. 32 indexed citations
10.
Li, Gang, et al.. (2021). Histopathological validation of safe margin for nephron-sparing surgery based on individual tumor growth pattern. World Journal of Surgical Oncology. 19(1). 255–255. 3 indexed citations
11.
Wang, Lili, et al.. (2021). Benefits from standalone durvalumab treatment in an elderly patient with advanced prostatic sarcoma: a case report. Translational Andrology and Urology. 10(11). 4298–4303. 1 indexed citations
12.
Yu, Jianpeng, et al.. (2019). Impact of squamous differentiation on intravesical recurrence and prognosis of patients with upper tract urothelial carcinoma. Annals of Translational Medicine. 7(16). 377–377. 6 indexed citations
13.
Wang, Aixiang, Longke Ran, Wanfeng Zhang, et al.. (2019). ARHGEF38 as a novel biomarker to predict aggressive prostate cancer. Genes & Diseases. 7(2). 217–224. 6 indexed citations
14.
Li, Gang�, et al.. (2018). Classification of positive surgical margins and tumor recurrence after nephron-sparing surgery for small renal masses. Cancer Management and Research. Volume 10. 6591–6598. 7 indexed citations
15.
Wang, Zhun, et al.. (2018). Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma. Clinica Chimica Acta. 486. 9–17. 20 indexed citations
16.
Wang, Zhun, Shuanghe Peng, Aixiang Wang, et al.. (2018). Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma. Clinica Chimica Acta. 480. 166–172. 37 indexed citations
17.
Du, E, Changwen Zhang, Kuo Yang, et al.. (2017). Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 35(4). 152.e7–152.e12. 1 indexed citations
18.
Li, Yibo, et al.. (2012). Experimental study on low temperature high pressure oxidation in air injection in light oil reservoir. Oil Drilling & Production Technology. 34(6). 90–92. 2 indexed citations
19.
Liu, Ting, et al.. (2005). Detecting expression of MRP-1/CD9 mRNA in lung cancers using tissue microarrays and fluorescence in situ hybridization methods. Chinese Journal of Cancer Research. 17(3). 199–202. 2 indexed citations
20.
Wang, Xinyun, Zhi Yao, Yan Li, et al.. (2004). Expression of survivin, PTEN and BFGF in lung cancer progression tissue microarray. Chinese Journal of Cancer Research. 16(4). 297–301. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026